Form 8-K · Item 4.01 · Auditor change
AbCellera Biologics Inc.: auditor change, KPMG LLP to Ernst & Young LLP
AbCellera Biologics Inc. reported in a Form 8-K filed November 28, 2025, that on November 24, 2025, KPMG LLP was dismissed as its certifying accountant, and Ernst & Young LLP was engaged.
In the filing's words
On November 24, 2025, the Audit Committee of the Board of Directors (the "Audit Committee") of AbCellera Biologics Inc. (the "Company") approved the dismissal of KPMG LLP ("KPMG") as the Company's independent registered public accounting firm
The dismissal was not related to any disagreements with KPMG on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure.
on November 24, 2025, the Audit Committee selected Ernst & Young LLP ("EY") as the Company's new independent registered public accounting firm for the fiscal year ending December 31, 2026
Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.
| Company | AbCellera Biologics Inc. |
|---|---|
| Ticker | ABCL |
| Form and item | 8-K, Item 4.01 |
| Filed with the SEC | November 28, 2025 |
| What the filing states | dismissed, engaged |
| Former accountant | KPMG LLP |
| New accountant | Ernst & Young LLP |
| Date of the change | November 24, 2025 |
| Disagreements | not stated |
| Auditor's letter | Exhibit 16 on sec.gov |
| Accession number | 0001703057-25-000032 |
| SEC CIK | 0001703057 |
AbCellera Biologics Inc. reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed November 28, 2025. The filing's own words are quoted above.
Sources
More: all auditor changes · Something wrong? Send a correction with the primary source.